Immune Response Completed Phase 4 Trials for Hepatitis B Vaccine (Recombinant) (DB11627)

IndicationStatusPhase
DBCOND0034832 (Immune Response)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01861613Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College StudentsPrevention